Announced a partnership with Sengenics, a leading genetic diagnostics company, to provide turn-key diagnostic decision making solutions for Asian and global markets. Sengenics plans to incorporate CollabRx's interpretive content resources into its molecular cancer diagnostics tests and reports.
CollabRx Partners With Sengenics for Molecular Diagnostics
globenewswire.com